Category: General

New Deals With Prosperous Countries For This Large Pharmaceutist: A Race Won?

AZN

COVID-19, General, HealthcareBy Omar September 7, 2020

Anyone who closely follows the situation surrounding the pandemic worldwide knows that in large parts of Europe the number of new cases with COVID-19 is increasing again. UK Health Minister, Matt Hancock, voiced his concerns on English radio today and is particularly appealing to young adults, who are known to be less serious at dealing…

Statistics from Ipsos show a disagreement among the population about a COVID-19 vaccine

COVID-19, General, HealthcareBy Omar September 4, 2020

It appears that about 25% of the people in the world do not intend to be vaccinated when a COVID-19 vaccine becomes available. Just under half of people from 27 countries think there will be a vaccine this year. A new poll by market research firm Ipsos shows that there are large differences between countries…

Is AstraZeneca the Vaccine Pioneer of the European Union?

AZN

COVID-19, General, HealthcareBy Omar September 4, 2020

The European Union hopes to receive 30 million doses of a potential corona vaccine by the end of this year, as part of the deal with British manufacturer AstraZeneca. Based on one dose per person, such a first batch would cover 6 to 7 percent of the EU population. The European Commission has signed a…

Sorrento Therapeutics Seems to Aim for a High Risk, High Reward Principle

SRNE

COVID-19, General, HealthcareBy Omar September 4, 2020

Sorrento Therapeutics (Ticker: SRNE) acquired SmartPharm this week for $18.6 million. The pharmaceutical company offered approximately 1.76 million shares to SmartPharm for $10.60 each. The motivation for this is to support efforts to further develop antibody treatments for COVID-19 and other diseases. Sorrento claims it has an antibody that grabs and then blocks the virus…

Why J&J is Delighted About the Syrian ‘Golden’ Hamsters in the Search of a Vaccine

JNJ

COVID-19, General, HealthcareBy Omar September 3, 2020

Who would have thought that Syrian golden hamsters could play a significant role in the search for a vaccine that still holds the world in its grip? Earlier today, Johnson & Johnson ($JNJ) announced in the medical journal “Nature Medicine” that in a preclinical study with these small rodents, the candidate vaccine, Ad26.COV2.S, prevented serious…

Why did Elon Musk visited Germany and CureVac?

CVAC

COVID-19, General, TechnologyBy Omar September 3, 2020

Tesla boss Elon Musk is in Germany for a series of visits. Yesterday afternoon he met the German Minister of Economic Affairs, Peter Altmaier. Therefore, the CEO of the electric car manufacturer visited a company that is currently working on a vaccine against the COVID-19. It was unclear whether he also visited the construction site…

Sonoran Flower Is About To Make Millions With CBD Thanks To COVID-19

EXMT

CBD, GeneralBy Omar September 3, 2020

Sonoran Flower LLC announced remarkable news this morning, a company also known as the subsidiary of Anything Technologies Media Inc. (OTCMKTS: EXMT). Sonoran has harvested 5 million feminized hemp seeds on a massive 12,000 square feet in an (indoor) facility located in Arizona. The cultivation counts 7 to 8 crops per year with a growth…

The R&M Only Believes In These 15 Pharmaceuticals In The Race Of The COVID-19 Vaccine

COVID-19, General, HealthcareBy Omar September 2, 2020

Breakout Stocks Corona Virus Stocks The world’s largest online market research store “Research and Markets” (R&M) has officially named 15 pharmaceutical companies at the forefront of the quest for the COVID-19 vaccine. Although in some parts of the world the state of the pandemic is slowly improving, future numbers of the virus are increasing and vaccine…

Why AstraZeneca Can Climb Again When Focusing On This Promising Treatment

AZN

General, HealthcareBy Omar September 2, 2020

AstraZeneca PLC ($AZN) announced remarkable numbers about the Farxiga study that includes positive data for the Phase III. The study result shows a significant decrease in the risk of renal failure, cardiovascular or renal death in patients suffering from chronic kidney disease. Further data from the Phase III DAPA-CKD study showed that Farxiga – in…

Why major pharmaceutical and biotech companies will keep growing for years

GILD

COVID-19, General, HealthcareBy Omar August 31, 2020

Several big pharmaceutical groups are undervalued according to Morningstar: Roche ($RHHBY), Bristol ($BMY), Merck ($MRK) and Pfizer ($PFE). These stocks are expected to grow an average of 5% annually through 2024. The COVID-19 pandemic has so far not had a major negative impact on expected performance. An expected average growth till 2024 The major pharmaceutical…

Category Archives: General